BGM Group Ltd Ordinary Shares - Class A BGM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $9.00
- Day Range
- $8.25–8.25
- 52-Week Range
- $0.00–291.30
- Bid/Ask
- $4.50 / $10.04
- Shares Outstanding
- 13.35M
- Market Cap
- $110.17M
- Volume/Avg
- 972 / 8,268
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.09
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 471
- Website
- https://www.bgmgroupltd.com
Valuation
Metric | BGM |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.14 |
Price/Sales | 1.09 |
Price/Cash Flow | 24.54 |
Price/Earnings
BGM
Financial Strength
Metric | BGM |
|---|---|
Quick Ratio | 0.65 |
Current Ratio | 1.25 |
Interest Coverage | — |
Quick Ratio
BGM
Profitability
Metric | BGM |
|---|---|
Return on Assets (Normalized) | −5.84% |
Return on Equity (Normalized) | −6.53% |
Return on Invested Capital (Normalized) | −6.49% |
Return on Assets
BGM
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|!Vl#<RZ@ | LOCK|kKmB> | $73B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|<yR$Z$C | LOCK|%@#> | $48B | |||
| Haleon PLC ADR HLN | LOCK|XG?%B< | LOCK|Y## | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|GjG>BhN | LOCK|@D | $32B | |||
| Viatris Inc VTRS | LOCK|BjXj?mX | LOCK|r@! | $23B | |||
| Elanco Animal Health Inc ELAN | LOCK|R@D | LOCK|<<S | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|m#wlGc | LOCK|lz | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|jpG%#r | LOCK|y?? | $6B | |||
| Perrigo Co PLC PRGO | LOCK|G$X^P!n | LOCK|V?b | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|L<x?xd# | LOCK|T%>f | $2B |
United States